Mk. Fehr et al., Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid, GYNECOL ONC, 80(1), 2001, pp. 62-66
Objectives. The aim of this study was twofold: first, to determine the feas
ibility of photodynamic therapy (PDT) of vulvar intraepithelial neoplasia I
II (VIN III) using topically applied 5-aminole-vulinic acid (ALA) for photo
sensitization, and second, to compare PDT results with those of laser evapo
ration and local excision.
Methods. Fifteen patients with VIN III had 10 g of 10% ALA gel applied to t
he entire vulva. Two to three hours after drug application the vulva was ir
radiated with 120 J/cm(2) laser light at a wavelength of 635 nm. The proced
ure was performed without anesthesia in most patients. Thirty patients with
VIN III treated by laser evaporation and 27 patients treated by surgical e
xcision served as controls.
Results. Eight weeks following PDT, 11 of 15 patients were free of VIN III
as determined by biopsy. Excellent tissue preservation was achieved and no
ulcers or scarring occurred. Three recurrences were seen during follow-up,
at 5, 6, and 7 months after PDT. Twelve months after treatment, analysis of
disease-free survival revealed no statistically significant difference bet
ween patients treated with PDT and patients treated with conventional treat
ment modalities (P = 0.67) but the power of this analysis is low, In multiv
ariate analysis, multifocal disease was the sole variable associated with a
reduced disease-free survival.
Conclusion. While PDT of VIN III seems to show efficacy similar to that of
conventional treatment modalities it offers unique advantages: healing time
is short, preservation of normal vulvar appearance is excellent, and PDT m
ay be performed without anesthesia. Hence, PDT of VIN III deserves further
investigation. (C) 2001 Academic Press.